Hormono-radiotherapy in prostatic carcinoma: prognostic factors and implications for combined modality treatment.

@article{Cellini2002HormonoradiotherapyIP,
  title={Hormono-radiotherapy in prostatic carcinoma: prognostic factors and implications for combined modality treatment.},
  author={Numa Cellini and Stefano Luzi and Alessio Giuseppe Morganti and Giovanna Mantini and Vincenzo Valentini and Marco Racioppi and Mariavittoria Leone and Gian Carlo Mattiucci and Cinzia Di Ges{\'u} and Mario Giustacchini and Antonio Destito and Daniela Smaniotto and Eugenio Alcini},
  journal={Tumori},
  year={2002},
  volume={88 6},
  pages={495-9}
}
The aim of this study was to evaluate the prognostic role of several clinical variables in a patient population undergoing neoadjuvant hormonotherapy (NHT) with external beam radiotherapy (ERT) to identify subsets of patients with an unfavorable prognosis who require intensified therapy. Eighty-four patients (mean age, 68.2 +/- 6.1 years; range, 52-81 years… CONTINUE READING